[Administration of 25-hydroxyvitamin D3 for the prevention of disorders of calcium-phosphate metabolism after anticonvulsant therapy in children].
D000293:Adolescent; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D002112:Calcifediol / Q000008:administration & dosage*; D002648:Child; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D012279:Rickets / Q000139:chemically induced / Q000517:prevention & control*
D000927:Anticonvulsants; D002112:Calcifediol
Podaz 25-hydroksywitaminy D3 w zapobieganiu zaburzeniom przemiany wapniowo-fosforanowej po lekach przeciwdrgawkowych u dzieci.